Maximum Entertainment (MAXENT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Q3 2024 net sales were €17.2M, down 32% year-over-year due to a lighter release schedule versus a strong Q3 2023 with major Owned IP launches.
Adjusted EBITDA was -€0.2M for the quarter, with a year-to-date figure of €3.0M.
Gross margin for Q3 was 24%, down from 33% in Q3 2023, reflecting a shift in product mix and fewer high-margin Owned IP releases.
EBIT was -€16.3M, including a one-off €13.2M impairment on capitalized development; adjusted EBIT was -€3.1M, an improvement over last year.
Headcount reduced to 181, a 24% decrease year-over-year, as part of ongoing cost-saving measures.
Financial highlights
Net sales for Q3 2024: €17.2M (Q3 2023: €25.3M); year-to-date: €54.5M (2023: €65.5M).
Adjusted EBITDA margin: -1% in Q3 2024 (Q3 2023: 16%).
Gross margin: 24% in Q3 2024 (Q3 2023: 33%).
EBIT: -€16.3M in Q3 2024 (Q3 2023: -€6.8M); adjusted for impairment, EBIT was -€3.1M.
Net loss for Q3 2024: -€20.3M (Q3 2023: -€9.8M); EPS before/after dilution: -€0.40.
Outlook and guidance
Q4 to feature key launches including Maximum Football (early access), new Fantasy Friends, and Diesel Legacy.
Focus for 2025: strengthen financial position, increase revenue, improve cost control, and prioritize faster turnaround, lower-risk projects.
Asset divestments and internal cost reductions planned to address cash flow needs.
Latest events from Maximum Entertainment
- Gross margin rose to 34% and adjusted EBITDA increased 15% YTD, with H2 set for major launches.MAXENT
Q2 20243 Feb 2026 - Net sales fell 26% to €25.5M amid restructuring, with legal and financing risks ongoing.MAXENT
Q4 20243 Feb 2026 - Sales and margins fell, but adjusted EBITDA improved; urgent financing and legal risks persist.MAXENT
Q3 20255 Nov 2025 - Sales and margins fell sharply, with liquidity and legal risks dominating the outlook.MAXENT
Q2 202513 Aug 2025 - Sales fell sharply and legal, financial risks persist despite cost cuts and new releases ahead.MAXENT
Q1 20256 Jun 2025